Atlas Trials

Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response

Clinical trial NCT03341429 · COMPLETED

Trial details

NCT number
NCT03341429
Sponsor
University College, London
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Obesity
Start date
2018-08-22
Primary completion
2019-11-28
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.